ప్రోస్టేట్ క్యాన్సర్
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
ఎక్కడికి వెళ్లాలి
ఈ trial కోసం ఇండియాలో 8 హాస్పిటల్స్ పేషెంట్లను తీసుకుంటున్నాయి.
రిజిస్ట్రీ సమ్మరీ (టెక్నికల్)
Researchers are looking for a better way to treat men who have non-metastatic castration-resistant prostate cancer (nmCRPC). This is a type of cancer of the prostate that has not yet spread to other parts of the body and that keeps progressing even when the amount of male sex hormones like testosterone (also called androgens) is reduced to very low levels. To reduce androgen levels in prostate cancer patients, androgen deprivation therapy (ADT) is often used. As androgens stimulate the growth of prostate cancer cells, low levels are needed to reduce or slow the growth of these tumors. In men …
స్పాన్సర్: Bayer
NCT05348876 on ClinicalTrials.gov
రిజిస్ట్రీలో చివరిగా అప్డేట్ అయిన తేదీ 6 Jul 2026 · మేము చదివిన తేదీ 20 Oct 2026